Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,395 | 19,927 | 62,132 | 118,264 | 121,094 |
| Marketable Securities | 63,392 | 81,246 | 53,948 | 8,588 | 17,568 |
| TOTAL | $97,018 | $106,353 | $120,998 | $132,011 | $142,715 |
| Non-Current Assets | |||||
| PPE Net | 581 | 453 | 241 | 236 | 237 |
| Other Non-Current Assets | 1,269 | 1,376 | 1,265 | 1,361 | 1,460 |
| TOTAL | $1,850 | $1,829 | $1,506 | $1,597 | $1,697 |
| Total Assets | $98,868 | $108,182 | $122,504 | $133,608 | $144,412 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,802 | 1,893 | 2,189 | 1,560 | 1,566 |
| Accrued Expenses | 8,316 | 4,827 | 6,851 | 6,367 | 5,887 |
| TOTAL | $10,481 | $7,124 | $9,450 | $8,335 | $7,910 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,303 | 1,088 | 1,009 | 1,116 | 1,184 |
| TOTAL | $1,303 | $1,088 | $1,009 | $1,116 | $1,184 |
| Total Liabilities | $11,784 | $8,212 | $10,459 | $9,451 | $9,094 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,366 | 2,511 | 2,453 | 2,448 | 2,446 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -151,790 | -136,683 | -123,083 | -110,076 | -97,764 |
| Other shareholders' equity | 12 | -43 | -26 | 168 | 64 |
| TOTAL | $87,084 | $99,970 | $112,045 | $124,157 | $135,318 |
| Total Liabilities And Equity | $98,868 | $108,182 | $122,504 | $133,608 | $144,412 |